As shown in Figure 1, through an integrated approach encompassing multi-omics analyses, we discovered and validated the pivotal role of HMGB2 in tumor metastasis and the immunosuppressive microenvironment of HCC, highlighting its potential as a therapeutic target and prognostic marker for HCC management. Here, HMGB2 is linked to hepatocellular carcinoma.